This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Analyst Blog: Archive
Alliant Energy to Post Q4 Earnings: What to Expect From the Stock?
by Zacks Equity Research
LNT gears up for Q4 results with storage expansion, data center demand and cost controls in focus, but earnings are seen declining year over year.
PNWPositive Net Change AESPositive Net Change IDAPositive Net Change LNTPositive Net Change
utilities
Ultragenyx Q4 Loss Wider Than Expected, Revenues Increase Y/Y
by Zacks Equity Research
RARE posts a wider-than-expected Q4 loss even as revenues jump 25% to $207 million, beating estimates. It also announces a strategic restructuring plan targeting profitability in 2027.
REGNPositive Net Change ALKSNegative Net Change RARENegative Net Change CSTLPositive Net Change
biotechnology biotechs earnings medical pharmaceuticals
Penske Q4 Earnings Miss Expectations, Dividend Raised
by Zacks Equity Research
PAG misses Q4 EPS estimates as profit drops 17.8% to $2.91 per share; revenues rise 0.6% and Commercial Vehicle Distribution sales jump 35.3%.
PAGNegative Net Change STRTPositive Net Change MODPositive Net Change MGDDYPositive Net Change
auto-tires-trucks autonomous-vehicles earnings
PacBio Q4 Earnings and Revenues Beat Estimates, Gross Margin Up
by Zacks Equity Research
PACB beats Q4 estimates as revenue jumps 14%, gross margin hits 41% and 2026 revenues are projected in the range of $165-$180M after strategic moves.
DVANegative Net Change CAHPositive Net Change PACBNegative Net Change DOCSPositive Net Change
earnings medical medical-devices
ALNY Q4 Earnings Beat, Sales Miss Despite Y/Y Growth, Stock Down
by Zacks Equity Research
Alnylam tops Q4 earnings estimates but misses on sales despite 85% revenue growth, as booming Amvuttra demand fails to lift shares.
ALNYPositive Net Change NVSPositive Net Change RHHBYNegative Net Change ALKSNegative Net Change
biotechnology biotechs earnings medical pharmaceuticals
Does Rigetti's $600M Cash Runway De-Risk Its 2026 Roadmap Execution?
by Harshit Gupta
RGTI enters 2026 with $600M in liquidity, funds 100+ qubit launches and cuts dilution risk as revenue volatility persists.
IONQPositive Net Change RGTIPositive Net Change QBTSPositive Net Change
computers internet
ASML Climbs 11% in a Month: Time to Buy, Sell or Hold the Stock?
by Subham Roy
ASML Holding jumps 11% in a month as AI-driven EUV demand, a EUR 38.8B backlog and rising 2026 estimates fuel bullish momentum despite valuation concerns.
KLACPositive Net Change ASMLNegative Net Change LRCXPositive Net Change AMATPositive Net Change
semiconductor
APLD's Energy Strategy is Evolving: Can it Drive Further Upside?
by Zacks Equity Research
Applied Digital ramps up on-site power and advanced cooling to ease AI bottlenecks, aiming to speed campus energisation and boost compute density.
APLDNegative Net Change NVTPositive Net Change VRTNegative Net Change
artificial-intelligence cloud-computing finance tech-stocks
Iron Mountain Q4 AFFO Beat, Storage Rental & Service Revenues Rise
by Zacks Equity Research
IRM tops Q4 estimates as revenues jump 16.6% and data center growth surges, while 2026 guidance signals steady momentum.
EQIXNegative Net Change IRMPositive Net Change DLRPositive Net Change
finance reit
Should Altria Stock Be Part of Your Portfolio Post Q4 Earnings?
by Swati Prasad
MO is supported by resilient margins, steady cash returns and pricing power despite ongoing cigarette volume declines.
MOPositive Net Change PMNegative Net Change BTINegative Net Change TPBPositive Net Change
consumer-staples tobacco